Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
NEW YORK, March 16, 2016 (GLOBE NEWSWIRE) -- Ember Therapeutics, Inc. (OTCQB:EMBT), a New ...
Favorable tolerability profile consistent with Phase 1 data ARGX-113 treatment resulted in a strong ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email